|
⚲
|
| Keyboard |
| Thomas Hess | |
|---|---|
| Firm | |
| Address | Daventry Group, LP 655 Third Avenue, 21st Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Voxel Capital Offshore Fund Ltd | 021-592785 | Director | |||
| Tharimmune Inc | 021-532392 | Executive Officer | 2.0 M of 2.0 M |
||
| Tharimmune Inc | 021-517415 | Executive Officer | 2.1 M of 2.1 M |
||
| Genomind Inc | 021-316836 | Executive Officer | 20.6 M of 21.7 M |
||
| Genomind Inc | 021-280649 | Executive Officer | 7.8 M of 13.8 M |
||
| Genomind Inc | 021-215591 | Executive Officer | 20.9 M of 25.9 M |
||
| Yaupon Therapeutics Inc | 021-150836 | Executive Officer | 2.0 M of 6.0 M |
||
| Yaupon Therapeutics Inc | 021-44768 | Executive Officer | 3.1 M of 3.5 M |
||
| Daventry Group LP | |||||
| Daventry Group Partners LP | 021-359799 | Executive Officer | 85.2 M | 7.1 M | |
| Daventry Group Partners Master Fund LP | 021-359799 | Executive Officer | 85.2 M | 58.1 M | |
| Daventry Group Partners Offshore Ltd | 021-359802 | Executive Officer | 127.4 M | 116.1 M | |